Decision To Screen For Prostate Cancer Should Include Patients, ACS Panel Says
In Brief: Ozer, Comis Join Allegheny Cancer Centers; Two Cooperative Groups Under Same Roof
FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy
FDA To Regulate Products From Human Cells, Tissue
NCI Extramural Program: Advisors Approve Concepts For Diagnostic Imaging Trials Group
In Congress: specer, Harkin Pan re-Introduction Of Research Trust Fund
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- The future of oncology: Early-career scientists need mentorship and a new academic model
- How will FDA regulate psychedelics?
- The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long” - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- OMB proposal to sideline peer review sparks widespread opposition
Nearly 500,000 public comments flood in—here are some highlights









